CDC’s Global AR Laboratory and Response Network and the Global Action in Healthcare Network (GAIHN) fill critical gaps for detecting and responding to deadly threats worldwide, no matter where they emerge—in health care, communities, or the environment. These global networks build upon CDC’s domestic AR laboratory, response, and infection prevention interventions, scaling proven solutions to address AR and infectious diseases globally.
CDC is also investing in short-term, global AR innovation research to find public health solutions that save lives and transform the global response to antimicrobial resistance across One Health.
“Antimicrobial resistance is not going away and new AR threats will continue to emerge. CDC’s domestic AR Lab Network is an established model for detecting emerging antimicrobial resistance threats. Today, these new investments will build on this model and span much of the globe, leveraging proven expertise to fill critical gaps and inform data-driven responses before threats can spread in communities, across borders, or around the world,” said Denise Cardo, MD, Director of CDC’s Division of Healthcare Quality Promotion. “We also know that evidence-based prevention in health care stops AR threats and other infectious diseases. These new programs will fill infection control gaps to keep patients safe and contain threats immediately when they do inevitably emerge.”
Read the full media statement.
